Adaptation for Regulatory Application: A Content Analysis of FDA Risk Evaluation and Mitigation Strategies Assessment Plans (2014-2018) Using RE-AIM
Background: Risk Evaluation and Mitigation Strategies (REMS) are safety programs that U.S. Food and Drug Administration can require to ensure a drug's benefits outweigh its risks and can be considered public health interventions. FDA's 2019 draft Guidance for Industry on REMS Assessments e...
Saved in:
Main Authors: | Gita A. Toyserkani (Author), Linda Huynh (Author), Elaine H. Morrato (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014-2018)
by: Linda Huynh, et al.
Published: (2021) -
Integrating risk minimization planning throughout the clinical development and commercialization lifecycle: an opinion on how drug development could be improved
by: Morrato EH, et al.
Published: (2015) -
Using Innovation-Corps (I-Corps™) Methods to Adapt a Mobile Health (mHealth) Obesity Treatment for Community Mental Health Settings
by: Rita Haddad, et al.
Published: (2022) -
RE-AIM in the Real World: Use of the RE-AIM Framework for Program Planning and Evaluation in Clinical and Community Settings
by: Bethany M. Kwan, et al.
Published: (2019) -
RE-AIM Planning and Evaluation Framework: Adapting to New Science and Practice With a 20-Year Review
by: Russell E. Glasgow, et al.
Published: (2019)